CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Grant or award Director acquired 65,430 shares (grant or award)
- 4 Grant or award Director acquired 65,430 shares (grant or award)
- 4 Grant or award Director acquired 65,430 shares (grant or award)
- 4 Grant or award Director acquired 65,430 shares (grant or award)
- 4 Open-market buy Director bought 33,785 shares at $0.89 ($30,190)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes EVP, R&D and CMO gave up 50,103 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 34,148 shares (to pay taxes)
- 4 Grant or award Director acquired 37,735 shares (grant or award)
- 4 Grant or award Director acquired 37,735 shares (grant or award)
- 4 Grant or award Director acquired 37,735 shares (grant or award)
- 4 Grant or award Director acquired 37,735 shares (grant or award)
- 4 Grant or award Director acquired 37,735 shares (grant or award)
- 4 Grant or award Director acquired 37,735 shares (grant or award)
- 4 Grant or award Director acquired 37,735 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 21,347 shares (to pay taxes)
- 4 Grant or award Director acquired 79,470 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 55,525 shares at $1.80 ($99,945)
Page 4 of 33 · 648 filings